The independent source for health policy research, polling, and news.
261-280 of 1,323 results
The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer鈥檚, experts say.
President Joe Biden is kicking off his reelection campaign in part by trying to finish a decades-long effort to establish parity in insurance benefits between mental and physical health. Meanwhile, House Republicans are working to add abortion and other contentious amendments to must-pass spending bills. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Anna Edney of Bloomberg, and Sarah Karlin-Smith of the Pink Sheet join 吃瓜不打烊鈥 chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews 吃瓜不打烊鈥 C茅line Gounder about her podcast 鈥淓pidemic.鈥 The new season focuses on the successful public health effort to eradicate smallpox.
Although nearly 40% of Americans 60 and older are obese, Medicare doesn鈥檛 cover weight loss medications. Meanwhile, studies haven鈥檛 thoroughly examined new drugs鈥 impact on older adults.
It鈥檚 been the summer of broken weather records around the world 鈥 for heat, rain, and wildfire smoke 鈥 advertising the risks of climate change in a big way. But, apparently, it鈥檚 not enough to break the logjam in Washington over how to address the growing climate crisis. Meanwhile, in Texas, women who were unable to get care for pregnancy complications took their stories to court, and Congress gears up to 鈥 maybe 鈥 do something about prescription drug prices. Alice Miranda Ollstein of Politico, Shefali Luthra of The 19th, and Rachel Cohrs of Stat join Julie Rovner, 吃瓜不打烊鈥 chief Washington correspondent, to discuss these issues and more. Also this week, Rovner interviews Meena Seshamani, the top administrator for the federal Medicare program.
The Food and Drug Administration鈥檚 approval is viewed as groundbreaking, but many details still must be figured out.
Pharmacy benefit managers, or PBMs, are companies that negotiate the prices of prescription drugs. Hear about their role in raising drug prices and the ongoing efforts to regulate this complex industry.
At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients.
Black patients and other minorities tend to be diagnosed at later stages of the disease, which would exclude them from use of Leqembi. Few Black people were included in the main trial of the drug.
To drive down costs, insurers are bypassing hospital system pharmacies and delivering high-priced infusion drugs, including some used in chemotherapy, via third-party pharmacies. Smarting from losing out on billing for those drugs, hospitals and clinics are trying to convince states to limit this practice, known as "white bagging."
Twelve of the largest drugstores in the U.S. sent shoppers鈥 sensitive health information to Facebook or other platforms, according to an investigation by The Markup and 吃瓜不打烊.
Supporters say the proposed rules would balance the goals of increasing access to health care and helping prevent medication misuse. Opponents say the rules would make it difficult for some patients 鈥 especially those in rural areas 鈥 to get care.
A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.
The views of the leader of a broad anti-vaccine movement who is now running for president are unchallenged in public forums run by several prominent Silicon Valley figures.
The bipartisan deal to extend the U.S. government鈥檚 borrowing authority includes future cuts to federal health agencies, but they are smaller than many expected and do not touch Medicare and Medicaid. Meanwhile, Merck & Co. becomes the first drugmaker to sue Medicare officials over the federal health insurance program鈥檚 new authority to negotiate drug prices. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Lauren Weber of The Washington Post, and Jessie Hellmann of CQ Roll Call join 吃瓜不打烊鈥 chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews 吃瓜不打烊 senior correspondent Sarah Jane Tribble, who reported the latest 吃瓜不打烊-NPR 鈥淏ill of the Month鈥 feature, about the perils of visiting the U.S. with European health insurance.
The 鈥淒iabetes Belt,鈥 as defined by the Centers for Disease Control and Prevention, comprises 644 mostly Southern counties where diabetes rates are high. Of those counties, 吃瓜不打烊 and NPR found, more than half also have high levels of medical debt.
Robert F. Kennedy Jr.鈥檚 official entry into the presidential race poses a thorny challenge for journalists: how to cover a candidate who鈥檚 opposed to vaccines without amplifying misinformation. And South Carolina becomes the latest state in the South to ban abortion after roughly six weeks of pregnancy. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Sarah Karlin-Smith of the Pink Sheet join 吃瓜不打烊 chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews 吃瓜不打烊 senior correspondent Aneri Pattani about her project to track the billions of dollars coming from opioid makers to settle lawsuits.
Colorado鈥檚 new Prescription Drug Affordability Board could cap what health plans and consumers pay for certain medications starting next year. The process will pit patient groups against one another.
Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by then-President Donald Trump.
Sen. Bernie Sanders鈥 broad statement that some U.S. drug prices are 10 times those of other nations doesn鈥檛 paint the full picture. Studies we examined generally found that U.S. prices were two to four times those in other countries, not 10.
Greene County, Tennessee, so far has received more than $2.7 million from regional and national settlements with opioid manufacturers and distributors. But most of the money is not going to help people and families harmed by addiction.
漏 2026 KFF